DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Operating income | −$537M |
| Net income | −$519M |
| EPS | −$3.33 |
| Free cash flow | −$480M |
Dyne Therapeutics, Inc.
$15.20−0.62 (−3.92%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Operating income | −$537M |
| Net income | −$519M |
| EPS | −$3.33 |
| Free cash flow | −$480M |